Bank Of America Corp Rvl Pharmaceuticals PLC Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.28 - $2.91 $2,200 - $5,002
1,719 Added 171900.0%
1,720 $4,000
Q4 2021

Feb 08, 2022
SELL
$0.98 - $3.06 $6,088 - $19,011
-6,213 Reduced 99.98%
1 $0
Q3 2021

Nov 15, 2021
BUY
$2.79 - $4.19 $9,661 - $14,509
3,463 Added 125.88%
6,214 $18,000
Q2 2021

Sep 13, 2021
BUY
$2.8 - $3.78 $7,702 - $10,398
2,751 New
2,751 $8,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email